We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Non-Invasive Saliva Test Measures Tetanus Immunity in Children within 15 Minutes

By LabMedica International staff writers
Posted on 10 Jul 2024

Tetanus is a bacterial infection that can be deadly but is preventable through vaccination. More...

Yet, over 20 million children globally do not receive essential childhood vaccinations, and the COVID-19 pandemic caused the coverage of the diphtheria-tetanus-pertussis vaccine to drop to its lowest in 15 years, placing more individuals at risk of severe illnesses. While there has been a general decline in tetanus worldwide, the disease still results in avoidable deaths in several low-middle-income countries (LMICs). In response, experts are now developing a non-invasive saliva test that - within 15 minutes - could identify children in the Global South who lack immunity to tetanus and may have missed crucial vaccinations.

Researchers at University of Birmingham (Birmingham, UK;) are working on a low-cost lateral flow test that allows for easy, quick immunity testing without the need for blood draws, which is the current standard. After initial laboratory tests, this new method will be put to the test in Rwanda. There, researchers will evaluate its effectiveness in real-world conditions and gauge its acceptance within the local community. The test is designed for use in various settings, from outreach programs and community gatherings to clinics and hospitals, and could significantly enhance access to immunity testing in areas where it's challenging to assess protective status and gather sero-epidemiological data. Being non-invasive and saliva-based, it eliminates the complications and costs associated with blood sampling, which is particularly beneficial for children. The researchers plan to extend trials of this test to other LMICs to measure immunity levels across different populations and support vaccination monitoring and strategy development.

“Our test shows if a person has protection against tetanus within 15 minutes. It can help identify individuals who are not protected and need vaccination,” said Dr. Jennifer Heaney, Research Fellow, University of Birmingham. “As tetanus vaccination features in all combined immunizations alongside other serious diseases, if an individual is unprotected against tetanus, they are also likely to be missing protection against other serious vaccine-preventable diseases. The test therefore can measure tetanus immunity but could also help identify broader gaps in vaccine provision.”

Related Links:
University of Birmingham 

 


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.